• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在残留效应时交叉设计的分析。

Analysis of the crossover design in the presence of residual effects.

作者信息

Lehmacher W

机构信息

Gesellschaft für Strahlen- und Umweltforschung (GSF), Institut für Medizinische Informatik und Systemforschung, Neuherberg, West Germany.

出版信息

Stat Med. 1991 Jun;10(6):891-9. doi: 10.1002/sim.4780100610.

DOI:10.1002/sim.4780100610
PMID:1876779
Abstract

When a residual effect is suspected in a two-period crossover trial, an analysis of the first-period data is often chosen instead of the potentially biased crossover analysis. This paper indicates how the usual crossover test has to be interpreted correctly and that its bias has two different consequences, namely a conservative or a liberal test decision if a positive (carryover) or a negative (withdrawal) residual effect exists. A multiple testing procedure is presented allowing for simultaneous crossover and first-period analysis controlling the experimental error rate. This procedure together with the correct interpretation of the crossover test enables many useful applications of crossover designs.

摘要

在两阶段交叉试验中,当怀疑存在残留效应时,通常会选择对第一阶段的数据进行分析,而不是采用可能存在偏差的交叉分析。本文指出了如何正确解读常规交叉检验,并且其偏差有两种不同的结果,即如果存在正向(延滞)或负向(撤药)残留效应,检验决策会偏保守或偏宽松。本文提出了一种多重检验程序,可同时进行交叉分析和第一阶段分析,控制实验错误率。该程序与交叉检验的正确解读相结合,使得交叉设计有许多有用的应用。

相似文献

1
Analysis of the crossover design in the presence of residual effects.存在残留效应时交叉设计的分析。
Stat Med. 1991 Jun;10(6):891-9. doi: 10.1002/sim.4780100610.
2
Using the maximum test statistic in the two-period crossover clinical trial.在两阶段交叉临床试验中使用最大检验统计量。
Biometrics. 1988 Mar;44(1):211-8.
3
The crossover experiment for clinical trials.
Biometrics. 1980 Mar;36(1):69-79.
4
A critique of recent research on the two-treatment crossover design.
Control Clin Trials. 1989 Sep;10(3):237-43. doi: 10.1016/0197-2456(89)90065-2.
5
A Bayesian analysis of the two-period crossover design for clinical trials.用于临床试验的两阶段交叉设计的贝叶斯分析。
Biometrics. 1985 Dec;41(4):979-90.
6
A simple method for the estimation of interaction bias in crossover studies.一种用于估计交叉研究中交互偏差的简单方法。
J Clin Pharmacol. 1990 Nov;30(11):1036-40. doi: 10.1002/j.1552-4604.1990.tb03591.x.
7
The performance of the two-stage analysis of two-treatment, two-period crossover trials.
Stat Med. 1989 Dec;8(12):1421-32. doi: 10.1002/sim.4780081202.
8
Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.五种延滞模型的最优和/或高效双处理交叉设计
Int J Biostat. 2018 Nov 24;14(2):/j/ijb.2018.14.issue-2/ijb-2018-0001/ijb-2018-0001.xml. doi: 10.1515/ijb-2018-0001.
9
Optimal crossover designs in the presence of carryover effects.存在残留效应时的最优交叉设计。
Biometrics. 1983 Dec;39(4):1087-91.
10
Crossover trials with a binary response: a powerful method despite the carryover effect.具有二元响应的交叉试验:尽管存在残留效应但仍是一种强大的方法。
J Clin Pharmacol. 1996 Mar;36(3):198-202. doi: 10.1002/j.1552-4604.1996.tb04188.x.

引用本文的文献

1
Physiologic Adaptation to Macronutrient Change Distorts Findings from Short Dietary Trials: Reanalysis of a Metabolic Ward Study.宏量营养素变化的生理适应扭曲了短期饮食试验的结果:代谢病房研究的再分析。
J Nutr. 2024 Apr;154(4):1080-1086. doi: 10.1016/j.tjnut.2023.12.017. Epub 2023 Dec 19.
2
A Bioequivalence Study of Avanafil in Healthy Chinese Male Subjects Under Fasting and Fed Conditions: Results of a Randomized, Open-Label, Single-Dose, 2-Sequence, 2-Period Crossover Study.一项在健康中国男性受试者中空腹和进食条件下阿伐那非的生物等效性研究:一项随机、开放标签、单剂量、2 序列、2 周期交叉研究的结果。
Clin Pharmacol Drug Dev. 2021 Dec;10(12):1495-1502. doi: 10.1002/cpdd.998. Epub 2021 Jul 19.
3
The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects.
代谢型谷氨酸受体 5 负变构调节剂非诺苯:在健康人体受试者中的药代动力学、副作用和镇痛作用。
Pain. 2020 Jan;161(1):135-146. doi: 10.1097/j.pain.0000000000001695.
4
The Use and Reporting of the Cross-Over Study Design in Clinical Trials and Systematic Reviews: A Systematic Assessment.交叉研究设计在临床试验和系统评价中的应用与报告:一项系统评估
PLoS One. 2016 Jul 13;11(7):e0159014. doi: 10.1371/journal.pone.0159014. eCollection 2016.
5
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.用地夫可特治疗肌营养不良蛋白病:一项双盲、安慰剂对照临床试验。
Orphanet J Rare Dis. 2013 Feb 14;8:26. doi: 10.1186/1750-1172-8-26.
6
Halitosis, oral health and quality of life during treatment with Invisalign(®) and the effect of a low-dose chlorhexidine solution.使用隐适美(®)治疗期间的口臭、口腔健康与生活质量以及低剂量洗必泰溶液的效果
J Orofac Orthop. 2010 Nov;71(6):430-41. doi: 10.1007/s00056-010-1040-6. Epub 2010 Nov 17.
7
Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.每日一次服用10毫克非洛地平缓释片与25毫克氢氯噻嗪治疗轻至中度高血压的比较。
Eur J Clin Pharmacol. 1991;41(3):197-9. doi: 10.1007/BF00315429.